Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 14 Show results per page	View Search Criteria \| Help With Results

Last Modified: 8/1/1997


1.		Phase III Randomized, Double-Blind Study of 9-CRA Topical Gel vs Vehicle Gel for AIDS-Related Kaposi's Sarcoma (Summary Last Modified 08/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				Pharmaceutical / Industry				LIGAND-L1057T-31 NCI-V96-0867

Last Modified: 4/1/1998 First Published: 12/1/1997


2.		Phase III Study of 9-cis-Retinoic Acid versus Tretinoin in Patients with Newly Diagnosed Acute Promyelocytic Leukemia (Summary Last Modified 04/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				LIGAND-L1057-77 NCI-V97-1291

Last Modified: 4/1/1995


3.		Phase I/II Pilot Study of Topical 9-CRA for Cutaneous Kaposi's Sarcoma in HIV-Positive Patients (Summary Last Modified 04/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				Pharmaceutical / Industry				MSKCC-94087A1 NCI-V94-0595

Last Modified: 12/1/1995


4.		Phase I/II Pilot Study of Topical 9-CRA for Cutaneous T-Cell Lymphoma (Summary Last Modified 12/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				Pharmaceutical / Industry				MDA-DM-94075 MSKCC-94098, NCI-V95-0620

Last Modified: 7/1/1997


5.		Phase I/II Study of 9-CRA/IFN-A for Metastatic or Recurrent Renal Cell Carcinoma (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				16 and over								CAN-NCIC-IND88 NCI-V95-0754, IND88

Last Modified: 4/1/1996


6.		Phase II Study of 9-CRA for Locally Advanced, Inoperable, or Recurrent Carcinoma of the Cervix (Summary Last Modified 04/96)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				AECM-1199508304 NCI-T95-0063H, T95-0063

Last Modified: 10/1/1997


7.		Phase II Study of Oral 9-cis-Retinoic Acid for AIDS-Related Kaposi's Sarcoma (Summary Last Modified 10/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				LIGAND-L1057-28 NCI-V96-0974

Last Modified: 4/1/1998


8.		Phase II Study of 9-cis-Retinoic Acid/Carboplatin in Carboplatin-Resistant Ovarian Cancer (Summary Last Modified 04/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				LIGAND-L1057-32 NCI-V96-1051

Last Modified: 8/1/1997


9.		Phase II Study of Oral 9-cis-Retinoic Acid for Advanced Hormone-Refractory Prostate Cancer (Summary Last Modified 08/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				LIGAND-L1057-33 NCI-V96-1052

Last Modified: 4/1/2001


10.		Phase II Study of Oral 9-cis-Retinoic Acid for AIDS-Related Kaposi's Sarcoma (Summary Last Modified 04/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				AMC-002 NCI-T96-0042H

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute